Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy : The PD MED Randomized Clinical Trial
Citation
Gray , R , Patel , S , Ives , N , Rick , C , Woolley , R , Muzerengi , S , Gray , A , Jenkinson , C , McIntosh , E , Wheatley , K , Williams , A , Clarke , C E & PD MED Collaborative Group 2021 , ' Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy : The PD MED Randomized Clinical Trial ' , JAMA Neurology , vol. 79 , no. 2 , pp. 131-140 . https://doi.org/10.1001/jamaneurol.2021.4736